Alivus Life Sciences Profit & Loss Annual

Trade
BSE: 543322 | NSE: ALIVUS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs
1,021.10 +5.35 (0.53%)Updated : 22 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2,283.212,161.222,123.211,885.17
Total Revenue 2,283.212,161.222,123.211,885.17
Costof Revenue Total 1,002.011,014.091,042.89905.50
Gross Profit 1,281.201,147.131,080.33979.67
Selling/ General/ Admin Expenses Total 576.07478.71463.52384.55
Depreciation/ Amortization 53.4542.0937.8833.39
Other Operating Expenses Total 29.5525.57-0.32-0.38
Total Operating Expense 1,661.081,560.461,543.971,323.06
Operating Income 622.14600.76579.25562.10
Interest Inc( Exp) Net- Non- Op Total 9.8628.27-13.51-90.50
Gain( Loss)on Saleof Assets -0.70-0.56-0.74-0.58
Other Net 0.000.14-0.07-0.08
Net Income Before Taxes 631.29628.61564.93470.94
Provisionfor Income Taxes 160.40161.65146.20119.36
Net Income After Taxes 470.89466.96418.72351.58
Net Income Before Extra Items 470.89466.96418.72351.58
Net Income 470.89466.96418.72351.58
Income Availableto Com Excl Extra Ord 470.89466.96418.72351.58
Income Availableto Com Incl Extra Ord 470.89466.96418.72351.58
Diluted Net Income 470.89466.96418.72351.58
Diluted Weighted Average Shares 12.2712.2511.7512.25
Diluted EPS Excluding Extra Ord Items 38.3838.1135.6328.69
DPS- Common Stock Primary Issue 22.5021.0021.00-
Diluted Normalized EPS 38.4338.1435.6728.73
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
433.70+10.90(2.58%)
2,399.10+49.10(2.09%)
787.65-40.40 (-4.88%)